Skip to main content
. 2018 Jul 27;62(8):e02214-17. doi: 10.1128/AAC.02214-17

TABLE 1.

In vitro activity of amino artemisinins against asexual P. falciparum parasites

Compound Metabolic readout
Proliferation readout
Cytotoxicity
IC50a (nM)
RIb IC50 (nM)
RIc IC50 (nM) W2 RId HepG2 cell viability (%)e EC50 (μM) for CHO cells
NF54 Dd2 NF54 K1
CQ 31.8 ± 9.9 119.0 ± 20.9 3.7 10 ± 3 154 ± 14 15.4 233 ± 49 23.3 >55f (ref. 93) NDg
MB 0.3 ± 0.8 12.6 ± 4.0 43.3 5.0 ± 0.8 6.45 ± 0.30 1.29 5.13 ± 0.31 1.03 ND 52.6 ± 4.5
Artemisinin 10.8 ± 1.6 17.5 ± 2.5 1.6 0.57 ± 0.01 0.8 ± 0.5 1.40 0.37 ± 0.11 0.65 ∼90 ND
DHA 0.8 ± 0.1 5.7 ± 2.0 7.1 2.51 ± 0.19 1.51 ± 0.33 0.60 1.74 ± 0.22 0.69 ND 25.2 ± 3.7
Artesunate 10.3 ± 0.8 40.5 ± 5.0 4.0 3.4 ± 0.7 4 ± 1 1.24 2.4 ± 0.4 0.72 ∼90 >354
Artemether 2.0 ± 0.1 17.3 ± 2.2 8.7 8 ± 1 9 ± 2 1.13 7 ± 1 0.86 ∼90 >335
Artemisone 3.0 ± 0.8 2.7 ± 0.3 0.9 1.2 ± 0.4 1.01 ± 0.19 0.85 1.6 ± 0.4 1.36 ∼75 >249
Artemiside 6.0 ± 1.8 8.2 ± 1.4 1.4 1.11 ± 0.17 1.6 ± 0.4 1.47 1.75 ± 0.27 1.58 ∼80 >271
10-Sulfamide 10.9 ± 3.4 16.9 ± 2.6 1.55 3 ± 1 1.79 ± 0.26 0.56 2.04 ± 0.11 0.64 ∼90 56.0 ± 4.6
10-Arylamine 7.8 ± 1.9 11.1 ± 1.0 1.41 1.3 ± 0.6 0.64 ± 0.10 0.48 3 ± 1 2.55 ∼90 2.9 ± 1.4
10-Piperazine 3.2 ± 1.4 1.7 ± 0.2 0.5 3.1 ± 0.4 1.9 ± 0.5 0.61 1.4 ± 0.7 0.45 ∼77 ND
10-Phenylurea 1.3 ± 0.8 7.5 ± 0.4 5.8 4.7 ± 1.5 2.9 ± 0.6 0.61 1.7 ± 0.5 0.36 ∼85 2.4 ± 1.0
a

The IC50s for asexual parasites were determined against drug-sensitive NF54 parasites or drug-resistant Dd2, K1, and W2 parasites using either a metabolic pLDH assay or a proliferative SYBR green I-based fluorescence assay. Data are means from at least three independent biological repeats performed in triplicate for both the metabolic and proliferative assays ± SEM and the mean from a single experiment performed in duplicate for cytotoxicity assays on the HepG2 and CHO cell lines ± SD.

b

Resistance index (RI) = IC50 for Dd2/IC50 for NF54.

c

Resistance index = IC50 for K1/IC50 for NF54.

d

Resistance index = IC50 for W2/IC50 for NF54.

e

Percent viability at 1,000× the IC50 against P. falciparum parasites.

f

The EC50 was 22 ± 0.4 μM (93).

g

ND, not determined.